Meiyu Wu

机构：Central South University, National Center for Nanoscience and Technology, Second Xiangya Hospital of Central South University

发表论文 70 篇 · 总被引 672 次 · h-index 11

代表论文

• Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review (2022 · Frontiers in Pharmacology · 被引 20)
• Systemic lupus erythematosus patients contain B‐cell receptor repertoires sensitive to immunosuppressive drugs (2022 · European Journal of Immunology · 被引 16)
• Application and Safety Research of Nanotechnology in Cosmetics: Current Status, Challenges, and Future Prospects (2025 · BioNanoScience · 被引 15)
• Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States (2024 · Frontiers in Immunology · 被引 14)
• Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study (2023 · BMC Medicine · 被引 11)
• Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study (2022 · PharmacoEconomics · 被引 11)